Skip to main content
Fig. 6 | Journal of Nanobiotechnology

Fig. 6

From: Development of artesunate intelligent prodrug liposomes based on mitochondrial targeting strategy

Fig. 6

In vivo side effects evaluation. A Hematological data of the mice intraperitoneal injected with different samples at the 22ed day post-injection. The terms are noted as followed: (i) white blood cells (WBC), (ii) red blood cells (RBC), (iii) platelets (PLT), (iv) haemoglobin (HGB), (v) haematocrit (HCT), (vi) mean platelet volume (MPV), (vii) mean corpuscular haemoglobin (MCH), (viii) mean corpuscular volume (MCV), and (ix) platelet distribution width (PDW). B Blood biochemical analysis at the 22ed day post-injection. The terms are following: (i) alanine transaminase (ALT), (ii)aspartate transaminase (AST), (iii)alkaline phosphatase (ALP), (iv)AST/ALT, (v)blood urea nitrogen (BUN) and (vi)creatinine (CR). Compared with Control group, *P < 0.05, **P < 0.01

Back to article page